Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on June 21, 2007

Stroke. 2007
Published online before print June 21, 2007, doi: 10.1161/STROKEAHA.107.483404
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/8/2322    most recent
STROKEAHA.107.483404v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reading, S. A.
Right arrow Articles by Brayden, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reading, S. A.
Right arrow Articles by Brayden, J. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Related Collections
Right arrow Other Vascular biology
Right arrow Brain Circulation and Metabolism
Right arrow Ion channels/membrane transport

Submitted on January 26, 2007
Accepted on February 20, 2007

Central Role of TRPM4 Channels in Cerebral Blood Flow Regulation

Stacey A. Reading PhD* and Joseph E. Brayden PhD

From the Department of Pharmacology, University of Vermont College of Medicine, Burlington.

* To whom correspondence should be addressed. E-mail: sreading{at}uvm.edu.

Background and Purpose--The transient receptor potential channel TRPM4 is critically linked to the myogenic constrictor response of cerebral arteries that occurs when intravascular pressure increases. This myogenic behavior is thought to be fundamentally involved in the mechanisms of blood flow autoregulation. In this study, we tested the hypothesis that TRPM4 channels in cerebrovascular myocytes contribute to cerebral blood flow autoregulation in vivo.

Methods--In vivo suppression of cerebrovascular TRPM4 expression was achieved by infusing antisense oligodeoxynucleotides into the cerebral spinal fluid of 400- to 550-g Sprague-Dawley rats at 80 µg · day-1 for 7 days using an osmotic pump that discharged into the lateral cerebral ventricle. Absolute cerebral blood flow measurements were obtained over a range of mean arterial pressures using fluorescent microsphere methods.

Results--Oligonucleotides infused into the cerebrospinal fluid were detected in the smooth muscle cells of pial arteries. Semi-quantitative RT-PCR indicated that the message for TRPM4 was decreased in the cerebral arteries of antisense-treated rats. Myogenic constriction was decreased by 70% to 85% in cerebral arteries isolated from TRPM4 antisense- compared with control sense-treated rats. Cerebral blood flow was significantly greater in TRPM4 antisense- versus sense-treated rats at resting and elevated mean arterial pressures, indicating that autoregulatory vasoconstrictor activity was compromised in TRPM4 antisense-treated animals.

Conclusions--In vivo suppression of TRPM4 decreases cerebral artery myogenic constrictions and impairs autoregulation, thus implicating TRPM4 channels and myogenic constriction as major contributors to cerebral blood flow regulation in the living animal.


Key words: autoregulation • cerebral blood flow • myogenic tone • TRPM4